Response to Urine Drug Testing in a Family Residency Practice.

J Addict Med

Behavioral Health Innovations, Initiative for Research and Education to Advance Community Health and Elson S. Floyd College of Medicine, Washington State University, Spokane, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA Department of Health Services, School of Public Health, University of Washington, Seattle, WA.

Published: March 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450156PMC
http://dx.doi.org/10.1097/ADM.0000000000000283DOI Listing

Publication Analysis

Top Keywords

response urine
4
urine drug
4
drug testing
4
testing family
4
family residency
4
residency practice
4
response
1
drug
1
testing
1
family
1

Similar Publications

The branched-chain amino acid-related isoleucic acid: recent research advances.

Plant Biol (Stuttg)

January 2025

Department of Environmental Health, Institute of Biochemical Plant Pathology, Helmholtz Zentrum München, Neuherberg, Germany.

Isoleucic acid (ILA) was identified in human patients with maple syrup urine disease (MSUD) half a century ago. MSUD patients, who are defective in the catabolism of branched-chain amino acids (BCAAs), that is, isoleucine, leucine, and valine, have urine with a unique maple syrup odour related to the accumulation of BCAA breakdown products, largely 2-keto acid derivatives and their reduced 2-hydroxy acids including ILA. A decade ago, ILA was identified in Arabidopsis thaliana.

View Article and Find Full Text PDF

Background: This study evaluated the combined effects of oxylanthanum carbonate (OLC), an investigational phosphate binder, and tenapanor, an approved sodium/hydrogen exchanger 3 (NHE3) inhibitor that reduces paracellular phosphate absorption, on urinary phosphate excretion in rats on a high phosphorus diet.

Methods: Sixty-four male Sprague Dawley rats were randomized into eight groups: vehicle; tenapanor (0.15 mg/kg) only; OLC (0.

View Article and Find Full Text PDF

A two-dimensional fluorescence and chemiluminescence orthogonal probe for discriminating and quantifying similar proteins.

Chem Sci

January 2025

Key Laboratory for Advanced Materials, Institute of Fine Chemicals, Feringa Nobel Prize Scientist Joint Research Center, Frontiers Science Center for Materiobiology and Dynamic Chemistry, School of Chemistry and Molecular Engineering, Center of Photosensitive Chemicals Engineering, East China University of Science and Technology Shanghai 200237 China

Given that proteins with minor variations in amino acid sequences cause distinct functional outcomes, identifying and quantifying similar proteins is crucial, but remains a long-standing challenge. Herein, we present a two-dimensional orthogonal fluorescence and chemiluminescence design strategy for the probe DCM-SA, which is sequentially activated by albumin-mediated hydrolysis, exhibiting light-up fluorescence and photo-induced cycloaddition generating chemiluminescence, enabling orthogonal signal amplification for discrimination of subtle differences between similar proteins. By orthogonalizing these dual-mode signals, a two-dimensional work curve of fluorescence and chemiluminescence is established to distinguish and quantify similar proteins HSA and BSA.

View Article and Find Full Text PDF

Liquid biopsy in cancer management: Integrating diagnostics and clinical applications.

Pract Lab Med

January 2025

Department of Pharmaceutical Sciences, School of Pharmaceutical Science, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, 226025, Lucknow, India.

Liquid biopsy is an innovative, minimally invasive diagnostic tool revolutionizing cancer management by enabling the detection and analysis of cancer-related biomarkers from bodily fluids such as blood, urine, or cerebrospinal fluid. Unlike traditional tissue biopsies, which require invasive procedures, liquid biopsy offers a more accessible and repeatable method for tracking cancer progression, detecting early-stage cancers, and monitoring therapeutic responses. The technology primarily focuses on analyzing circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other cancer-derived genetic materials.

View Article and Find Full Text PDF

Objective: The effectiveness of using as an adjuvant therapy for patients with renal dysfunction (RD), especially acute kidney injury (AKI), is still a topic of debate. In response to the current conflicting data, the present meta-analysis was conducted to assess the clinical effectiveness of in the treatment of RD and to provide evidence for clinical practice.

Methods: Several databases, including PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI) and Wanfang, were systematically searched updated to March 25, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!